These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38907254)

  • 1. Reducing economic burden through split-shared care model for people living with uncontrolled type 2 diabetes and polypharmacy: a multi-center randomized controlled trial.
    Lum ZK; Tan JY; Wong CSM; Kok ZY; Kwek SC; Tsou KYK; Gallagher PJ; Lee JY
    BMC Health Serv Res; 2024 Jun; 24(1):760. PubMed ID: 38907254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of multidisciplinary collaborative care versus usual care in the management of high-risk patients with diabetes in Singapore: Short-term results from a randomized controlled trial.
    Siaw MYL; Malone DC; Ko Y; Lee JY
    J Clin Pharm Ther; 2018 Dec; 43(6):775-783. PubMed ID: 29696669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial.
    Siaw MYL; Ko Y; Malone DC; Tsou KYK; Lew YJ; Foo D; Tan E; Chan SC; Chia A; Sinaram SS; Goh KC; Lee JY
    J Clin Pharm Ther; 2017 Aug; 42(4):475-482. PubMed ID: 28449205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing diabetes care with community pharmacist-involved collaborative care model: A multi-centre randomised controlled trial.
    Lum ZK; Chang KL; Tsou KY; Tan JY; Wong CSM; Kok ZY; Kwek SC; Gallagher PJ; Lee JY
    Diabetes Res Clin Pract; 2022 Mar; 185():109238. PubMed ID: 35131378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical and cost-effectiveness of collaborative care in people with uncontrolled type 2 diabetes mellitus and polypharmacy: A multicenter randomized controlled trial.
    Xu Y; Tan CWY; Tsou KYK; Tan DHY; Gallagher PJ; Lee JY
    Prim Care Diabetes; 2022 Feb; 16(1):188-195. PubMed ID: 34953748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation.
    Stuhec M; Gorenc K; Zelko E
    BMC Health Serv Res; 2019 Feb; 19(1):118. PubMed ID: 30760276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
    Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
    J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes.
    McAdam-Marx C; Dahal A; Jennings B; Singhal M; Gunning K
    J Manag Care Spec Pharm; 2015 Jun; 21(6):452-68. PubMed ID: 26011547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: results from the North Carolina polypharmacy initiative.
    Trygstad TK; Christensen D; Garmise J; Sullivan R; Wegner S
    J Manag Care Pharm; 2005 Sep; 11(7):575-83. PubMed ID: 16137215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
    Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
    J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A shared medication scheme for community dwelling older patients with polypharmacy receiving home health care: role of the community pharmacist.
    Foubert K; Mehuys E; Claes L; Van Den Abeele D; Haems M; Somers A; Petrovic M; Boussery K
    Acta Clin Belg; 2019 Oct; 74(5):326-333. PubMed ID: 30235081
    [No Abstract]   [Full Text] [Related]  

  • 14. Financial Sustainability of an Oregon Rural Health, Primary Care, and Pharmacist-Run Comprehensive Medication Management Program Through Direct Medical Billing.
    Hoover ND; Turner RB; Sampson J; Pye T; Hotan T
    J Manag Care Spec Pharm; 2020 Jan; 26(1):30-34. PubMed ID: 31880232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment reviews of older people on polypharmacy in primary care: cluster controlled trial comparing two approaches.
    Denneboom W; Dautzenberg MG; Grol R; De Smet PA
    Br J Gen Pract; 2007 Sep; 57(542):723-31. PubMed ID: 17761060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients.
    Sellors J; Kaczorowski J; Sellors C; Dolovich L; Woodward C; Willan A; Goeree R; Cosby R; Trim K; Sebaldt R; Howard M; Hardcastle L; Poston J
    CMAJ; 2003 Jul; 169(1):17-22. PubMed ID: 12847034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes.
    Gerber BS; Rapacki L; Castillo A; Tilton J; Touchette DR; Mihailescu D; Berbaum ML; Sharp LK
    BMC Public Health; 2012 Oct; 12():891. PubMed ID: 23088168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoeconomic analysis of the diabetes initiative program: a pharmacist-physician collaborative care model.
    Franklin BE; Farland MZ; Thomas J; McFarland MS; Ray SM; Byrd DC
    Ann Pharmacother; 2013 Dec; 47(12):1627-34. PubMed ID: 24259610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic outcomes of pharmacist-physician medication therapy management for polypharmacy elderly: A prospective, randomized, controlled trial.
    Lin HW; Lin CH; Chang CK; Chou CY; Yu IW; Lin CC; Li TC; Li CI; Hsieh YW
    J Formos Med Assoc; 2018 Mar; 117(3):235-243. PubMed ID: 28549592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.